Breast Cancer

Merck advancing breast cancer drug to mid-stage

Drugmaker Merck & Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.

Dec 10, 2014
popularity not rated yet | comments 0

New breast cancer classification based on epigenetics

Breast cancer is the most common in women. One in nine will suffer breast cancer over their lifetime. Progress in prevention and early detection, and the use of chemotherapy after surgery (adjuvant chemotherapy), ...

Dec 10, 2014
popularity 5 / 5 (2) | comments 0

Latest Spotlight News

Echolocation acts as substitute sense for blind people

Recent research carried out by scientists at Heriot-Watt University has demonstrated that human echolocation operates as a viable 'sense', working in tandem with other senses to deliver information to people with visual impairment.

Bone loss drugs may help prevent endometrial cancer

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...